Glycopyrrolate Injection
Product Images NDC 71288-415
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71288-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Gly0a 0001 02 V2)
This is a description of a prescription medication called Glycopyrrolate Injection, USP. It is intended for intramuscular or intravenous use and is contained in a single dose vial of 1 mL. The medication contains benzyl alcohol and has the NDC code 71288-41401. It is manufactured for Meitheal Pharmaceuticals in Chicago, USA, and is produced in China. The document includes a barcode and copyright information for Meitheal Pharmaceuticals.*
Figure (Gly0a 0001 03 V2)
Figure (Gly0a 0001 04 V2)
This is a description for a medication called Glycopyrrolate, provided in a 2ml single-dose vial for intramuscular or intravenous use. It contains benzyl alcohol and the lot number is 3232SBL. The medication is manufactured by Meitheal Pharmaceuticals in Chicago, IL (USA) and made in China. The image quality is low, but the relevant information is still readable.*
Figure (Gly0a 0001 05 V2)
This looks like a product label for a medication called Glycopyrrolate Injection, for intramuscular or intravenous use. The label warns that the product is not suitable for newborns, and contains benzyl alcohol. The dosage instructions are not available, but there is accompanying descriptive literature. The product should be stored at 20-25C, and any unused portions should be discarded. It is sterile and non-pyrogenic. The product is described as being made without natural b-tex.*
Figure (Gly0a 0001 06 V2)
This is a description of a prescription medication presented in the form of a multi-dose vial. The medication is for intramuscular or intravenous use and contains Benzyl Alcohol NF as a preservative. The injection is mixed with hydrochloric acid B &3 2e when necessary and should be stored at a temperature of 20-25°C. The dosage and any further instructions are provided in an accompanying slot, and it should not be used for newborns.*
Figure (Gly0a 0001 07 V2)
Glycopyrrolate is a medication that comes in the form of an injection and is stored at a controlled room temperature of 25°C. The injection contains 0.2 mg per mL of Glycopyrrolate and is labeled as USP Injection, USP Injection, USP Injection. The rest of the text is not-readable and appears to be random characters.*
Figure (Gly0a 0001 08 V2)
Glycopyrrolate Injection, USP is a medication used for intramuscular or intravenous use. It contains Benzyl Alcohol, NF, which is a preservative and should not be used in newborns. The medication is available in a 20mL multi-dose vial with NDC71288-415-20 for prescription only. It is manufactured by Methaithel Pharmaceuticals, located in 60631 (USA), with a shelf temperature of 20°to 25°C (68°to 77°F). The container is sterile, nonpyrogenic and not made with natural rubber latex.*
Principal Display Panel – Glycopyrrolate Injection, Usp 20 mL Carton (Gly0a 0001 09 V2)
This is a description of Glycopyrrolate Injection, USP which is a sterile, non-pyrogenic medication for intravenous and intramuscular use. It contains 0.2mg/mL of Glycopyrrolate and is stored at a temperature between 20 to 25 degrees Celsius. The medication must not be used on newborns and contains Benzyl Alcohol. The pH of the medication is adjusted using Hydrochloric Acid and/or Sodium Hydroxide. The container closure is not made from natural rubber latex. The NDC code for this product is 288-415-21.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.